96. Crohn disease Clinical trials / Disease details

Clinical trials : 2,400 / Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01094613 (ClinicalTrials.gov)	November 2010	25/3/2010	Multicenter Clinical Efficacy and Safety Study of Delayed Release 6MP in Crohn's Disease	MultiCTR Randomized Double-Blind Double-Dummy Study to Evaluate Clinical Efficacy/Safety of DR 6MP for Targeted Ileal Delivery vs Purinethol in Patients w/Moderately Active Crohn's Disease	Crohn's Disease	Drug: Delayed Release 6 mercaptopurine;Drug: 6 Mercaptopurine	Teva GTC	NULL	Terminated	18 Years	75 Years	Both	70	Phase 1/Phase 2	Israel
2	NCT00774982 (ClinicalTrials.gov)	December 2008	16/10/2008	Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients	Pilot, Randomized, Open-Label, Two-Way Crossover Comparative Bioavailability Study of 40 mg Delayed Release Oral 6Mercaptopurine Versus 100 mg Purinethol in Patients With Crohns Disease	Crohns Disease	Drug: Delayed Release 6 mercaptopurine;Drug: 6 Mercaptopurine	Teva GTC	NULL	Completed	18 Years	50 Years	Both	12	Phase 1	Israel